Troglitazone inhibits cell proliferation by attenuation of epidermal growth factor receptor signaling independent of peroxisome proliferator-activated receptor γ

Cell Research

Volumn 19, Issue 6, 2009, Pages 720-732

  Li, Xiaoqi ^a   Yang, Xuanming ^a   Xu, Youli ^a   Jiang, Xuejun ^b   Li, Xin ^c   Nan, Fajun ^c   Tang, Hong ^a  

^a INSTITUTE OF BIOPHYSICS   (China)

^b INSTITUTE OF MICROBIOLOGY   (China)

^c SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Endocytosis; Growth arrest; Keywords: EGFR; PPAR?; Troglitazone

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; CHROMAN DERIVATIVE; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN KINASE B; TROGLITAZONE;

ANIMAL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG EFFECT; DRUG POTENTIATION; HUMAN; METABOLISM; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SWINE;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CHROMANS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; PHOSPHORYLATION; PPAR GAMMA; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; SWINE; THIAZOLIDINEDIONES;

EID: 67649970539     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2009.53     Document Type: Article

References (51)

1. Mangelsdorf DJ, Thummel C, Beato M, et a.. The nuclear receptor superfamily: the second decade. Cel. 1995; 83:835-839.
2. Evans RM, Barish GD, Wang YX. PPARs and the complex journey to obesity. Nat Me. 2004; 10:355-361.
3. Kliewer SA, Forman BM, Blumberg B, et a.. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci US. 1994; 91:7355-7359.
4. Issemann I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Natur. 1990; 347:645-650.
5. Dreyer C, Krey G, Keller H, et a.. Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cel. 1992; 68:879-887.
6. Berger J, Moller DE. The mechanisms of action of PPARs. Annu Rev Me. 2002; 53:409-435.
7. Tontonoz P, Hu E, Spiegelman BM. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cel. 1994; 79:1147-1156.
8. Tontonoz P, Singer S, Forman BM, et a.. Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor. Proc Natl Acad Sci US. 1997; 94:237-241.
9. Demetri GD, Fletcher CD, Mueller E, et a.. Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma. Proc Natl Acad Sci US. 1999; 96:3951-3956.
10. Elstner E, Muller C, Koshizuka K, et a.. Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitr. and in BNX mice. Proc Natl Acad Sci US. 1998; 95:8806-8811.
11. Koeffler HP. Peroxisome proliferator-activated receptor gamma and cancers. Clin Cancer Re. 2003; 9:1-9.
12. Kubota T, Koshizuka K, Williamson EA, et a.. Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitr. and in viv.. Cancer Re. 1998; 58:3344-3352.
13. Sarraf P, Mueller E, Jones D, et a.. Differentiation and reversal of malignant changes in colon cancer through PPARgamma. Nat Me. 1998; 4:1046-1052.
14. Yin F, Bruemmer D, Blaschke F, et a.. Signaling pathways involved in induction of GADD45 gene expression and apoptosis by troglitazone in human MCF-7 breast carcinoma cells. Oncogen. 2004; 23:4614-4623.
15. Baek SJ, Wilson LC, Hsi LC, Eling TE. Troglitazone, a peroxisome proliferator-activated receptor gamma (PPAR gamma) ligand, selectively induces the early growth response-1 gene independently of PPAR gamma. A novel mechanism for its antitumorigenic activity. J Biol Che. 2003; 278:5845-5853.
16. Akasaki Y, Liu G, Matundan HH, et a.. A peroxisome proliferator- activated receptor-gamma agonist, troglitazone, facilitates caspase-8 and -9 activities by increasing the enzymatic activity of protein-tyrosine phosphatase-1B on human glioma cells. J Biol Che. 2006; 281:6165-6174.
17. Feinstein DL, Spagnolo A, Akar C, et a.. Receptor-independent actions of PPAR thiazolidinedione agonists: is mitochondrial function the key? Biochem Pharmaco. 2005; 70:177-188.
18. Shiau CW, Yang CC, Kulp SK, et a.. Thiazolidenediones mediate apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 functions independently of PPARgamma. Cancer Re. 2005; 65:1561-1569.
19. Palakurthi SS, Aktas H, Grubissich LM, Mortensen RM, Halperin JA. Anticancer effects of thiazolidinediones are independent of peroxisome proliferator-activated receptor gamma and mediated by inhibition of translation initiation. Cancer Re. 2001; 61:6213-6218.
20. Hynes NE, Lane HA. ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cance. 2005; 5:341-354.
21. Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network. Nat Rev Mol Cell Bio. 2001; 2:127-137.
22. Le Roy C, Wrana JL. Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling. Nat Rev Mol Cell Bio. 2005; 6:112-126.
23. Sorkin A, Von Zastrow M. Signal transduction and endocytosis: close encounters of many kinds. Nat Rev Mol Cell Bio. 2002; 3:600-614.
24. Moscatello DK, Holgado-Madruga M, Godwin AK, et a.. Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors. Cancer Re. 1995; 55:5536-5539.
25. Gardner OS, Dewar BJ, Earp HS, Samet JM, Graves LM. Dependence of peroxisome proliferator-activated receptor ligand-induced mitogen-activated protein kinase signaling on epidermal growth factor receptor transactivation. J Biol Che. 2003; 278:46261-46269.
26. Gardner OS, Shiau CW, Chen CS, Graves LM. Peroxisome proliferator- activated receptor gamma-independent activation of p38 MAPK by thiazolidinediones involves calcium/ calmodulin-dependent protein kinase II and protein kinase R. correlation with endoplasmic reticulum stress. J Biol Che. 2005; 280:10109-10118.
27. Calnek DS, Mazzella L, Roser S, Roman J, Hart CM. Peroxisome proliferator-activated receptor gamma ligands increase release of nitric oxide from endothelial cells. Arterioscler Thromb Vasc Bio. 2003; 23:52-57.
28. Li M, Lee TW, Yim AP, Mok TS, Chen GG. Apoptosis induced by troglitazone is both peroxisome proliferator-activated receptor-gamma- and ERK-dependent in human non-small lung cancer cells. J Cell Physio. 2006; 209:428-438.
29. Willson TM, Brown PJ, Sternbach DD, Henke BR. The PPARs: from orphan receptors to drug discovery. J Med Che. 2000; 43:527-550.
30. Khan EM, Heidinger JM, Levy M, et a.. Epidermal growth factor receptor exposed to oxidative stress undergoes Src- and caveolin-1-dependent perinuclear trafficking. J Biol Che. 2006; 281:14486-14493.
31. Sigismund S, Woelk T, Puri C, et a.. Clathrin-independent endocytosis of ubiquitinated cargos. Proc Natl Acad Sci US. 2005; 102:2760-2765.
32. Waterman H, Yarden Y. Molecular mechanisms underlying endocytosis and sorting of ErbB receptor tyrosine kinases. FEBS Let. 2001; 490:142-152.
33. Chaffer CL, Thomas DM, Thompson EW, Williams ED. PPARgamma-independent induction of growth arrest and apoptosis in prostate and bladder carcinoma. BMC Cance. 2006; 6:53.
34. Keshamouni VG, Reddy RC, Arenberg DA, et a.. Peroxisome proliferator-activated receptor-gamma activation inhibits tumor progression in non-small-cell lung cancer. Oncogen. 2004; 23:100-108.
35. Goetze S, Eilers F, Bungenstock A, et a.. PPAR activators inhibit endothelial cell migration by targeting Akt. Biochem Biophys Res Commu. 2002; 293:1431-1437.
36. Tatin F, Varon C, Genot E, Moreau V. A signalling cascade involving PKC, Src and Cdc42 regulates podosome assembly in cultured endothelial cells in response to phorbol ester. J Cell Sc. 2006; 119:769-781.
37. Ichiki T, Tokunou T, Fukuyama K, et a.. 15-Deoxy-Delta12, 14-prostaglandin J2 and thiazolidinediones transactivate epidermal growth factor and platelet-derived growth factor receptors in vascular smooth muscle cells. Biochem Biophys Res Commu. 2004; 323:402-408.
38. Sorkina T, Huang F, Beguinot L, Sorkin A. Effect of tyrosine kinase inhibitors on clathrin-coated pit recruitment and internalization of epidermal growth factor receptor. J Biol Che. 2002; 277:27433-27441.
39. Lennon AM, Ramauge M, Dessouroux A, Pierre M. MAP kinase cascades are activated in astrocytes and preadipocytes by 15-deoxy-Delta(12-14)-prostaglandin J(2) and the thiazolidinedione ciglitazone through peroxisome proliferator activator receptor gamma-independent mechanisms involving reactive oxygenated species. J Biol Che. 2002; 277:29681-29685.
40. Mounho BJ, Thrall BD. The extracellular signal-regulated kinase pathway contributes to mitogenic and antiapoptotic effects of peroxisome proliferators in vitr.. Toxicol Appl Pharmaco. 1999; 159:125-133.
41. Rokos CL, Ledwith BJ. Peroxisome proliferators activate extracellular signal-regulated kinases in immortalized mouse liver cells. J Biol Che. 1997; 272:13452-13457.
42. Fischer OM, Hart S, Gschwind A, Ullrich A. EGFR signal transactivation in cancer cells. Biochem Soc Tran. 2003; 31:1203-1208.
43. Hu E, Kim JB, Sarraf P, Spiegelman BM. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma. Scienc. 1996; 274:2100-2103.
44. Hedvat M, Jain A, Carson DA, et a.. Inhibition of HERkinase activation prevents ERK-mediated degradation of PPARgamma. Cancer Cel. 2004; 5:565-574.
45. Zhao X, Dai W, Zhu H, et a.. Epidermal growth factor (EGF) induces apoptosis in a transfected cell line expressing EGF receptor on its membrane. Cell Biol In. 2006; 30:653-658.
46. Kamer AR, Sacks PG, Vladutiu A, Liebow C. EGF mediates multiple signals: dependence on the conditions. Int J Mol Me. 2004; 13:143-147.
47. Tari AM, Hung MC, Li K, Lopez-Berestein G. Growth inhibition of breast cancer cells by Grb2 downregulation is correlated with inactivation of mitogen-activated protein kinase in EGFR, but not in ErbB2, cells. Oncogen. 1999; 18:1325-1332.
48. Dankort D, Maslikowski B, Warner N, et a.. Grb2 and Shc adaptor proteins play distinct roles in Neu (ErbB-2)-induced mammary tumorigenesis: implications for human breast can cer. Mol Cell Bio. 2001; 21:1540-1551.
49. Jiang X, Sorkin A. Coordinated traffic of Grb2 and Ras during epidermal growth factor receptor endocytosis visualized in living cells. Mol Biol Cel. 2002; 13:1522-1535.
50. Chen Y, Chen J, Xiong Y, et a.. Internalization of CD40 regulates its signal transduction in vascular endothelial cells. Biochem Biophys Res Commu. 2006; 345:106-117.
51. Chen J, Chen L, Wang G, Tang H. Cholesterol-dependent and -independent CD40 internalization and signaling activation in cardiovascular endothelial cells. Arterioscler Thromb Vasc Bio. 2007; 27:2005-2013.